1. Home
  2. LAND vs MYGN Comparison

LAND vs MYGN Comparison

Compare LAND & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gladstone Land Corporation

LAND

Gladstone Land Corporation

HOLD

Current Price

$8.88

Market Cap

414.1M

Sector

Real Estate

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.82

Market Cap

372.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LAND
MYGN
Founded
1997
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
414.1M
372.1M
IPO Year
2010
1996

Fundamental Metrics

Financial Performance
Metric
LAND
MYGN
Price
$8.88
$5.82
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
★ $9.33
$4.11
AVG Volume (30 Days)
514.6K
★ 2.7M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 6.37%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$88,339,000.00
★ $771,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.24
$5.47
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.66
2.33
52 Week Low
$7.92
$2.74
52 Week High
$13.00
$8.50

Technical Indicators

Market Signals
Indicator
LAND
MYGN
Relative Strength Index (RSI) 39.20 74.13
Support Level $7.95 $5.57
Resistance Level $8.90 $6.34
Average True Range (ATR) 0.27 0.33
MACD -0.10 0.16
Stochastic Oscillator 25.48 92.25

Price Performance

Historical Comparison
LAND
MYGN

About LAND Gladstone Land Corporation

Gladstone Land Corp is an externally-managed, agricultural REIT. It is mainly in the business of owning and leasing farmland. It manages operations in one reporting segment: Real Estate Rental Operations. It is focused on the ownership of farms and farm-related properties that are leased on a triple-net basis to tenants with a good operating history and deep farming resources. The farmland is predominantly concentrated in locations where farmers are able to grow either fresh produce or annual row crops (e.g., certain berries and vegetables), which are typically planted and harvested annually, or certain permanent crops (e.g., almonds, blueberries, pistachios, and wine grapes). To a much lesser extent, it also owns farms that grow certain commodity crops (e.g., corn and beans).

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: